SAN FRANCISCO, May 05, 2021 (GLOBE NEWSWIRE) -- Excision BioTherapeutics (“Excision”), a leading developer of potentially curative CRISPR anti-viral therapies to improve patient lives, today announced ...
SAN FRANCISCO, Oct. 20, 2022 (GLOBE NEWSWIRE) -- Excision BioTherapeutics, Inc., a clinical-stage biotechnology company developing CRISPR-based therapies intended to cure viral infectious diseases, ...
PARIS--(BUSINESS WIRE)--WhiteLab Genomics, a technology development company specialized in engineering data science solutions for the discovery and development of genomic medicine, today announced the ...
BOSTON--(BUSINESS WIRE)--GRO Biosciences Inc. (“GRObio”), an emerging biotechnology company leveraging synthetic biology to expand the amino acid alphabet and deliver on the promise of protein ...
Scientific and business leaders will reinforce our expertise as we develop data science and machine learning solutions for genomic medicine. WhiteLab Genomics, a technology development company ...